Private Capital Group, LLC Biogen Inc. Transaction History

Private Capital Group, LLC

$133 Million
Q2 2022

A detailed history of Private Capital Group, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Private Capital Group, LLC holds 54 shares of BIIB stock, worth $10,467. This represents 0.01% of its overall portfolio holdings.

Number of Shares

Previous 60 10.0%

Holding current value

$10,467

Previous $13,000 15.38%

% of portfolio

0.01%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 28, 2022	SELL	$187.54 - $223.02 $1,125 - $1,338	-6 Reduced 10.0%	54 $11,000
Q1 2022 Apr 21, 2022	SELL	$193.77 - $244.14 $387 - $488	-2 Reduced 3.23%	60 $13,000
Q4 2021 Jan 24, 2022	SELL	$223.92 - $287.77 $11,867 - $15,251	-53 Reduced 46.09%	62 $15,000
Q3 2021 Oct 13, 2021	BUY	$282.99 - $369.05 $2,263 - $2,952	8 Added 7.48%	115 $33,000
Q2 2021 Jul 26, 2021	SELL	$259.0 - $414.71 $25,641 - $41,056	-99 Reduced 48.06%	107 $37,000
Q1 2021 Apr 12, 2021	SELL	$242.95 - $284.63 $21,136 - $24,762	-87 Reduced 29.69%	206 $58,000
Q4 2020 Jan 26, 2021	BUY	$236.26 - $355.63 $5,433 - $8,179	23 Added 8.52%	293 $72,000
Q3 2020 Nov 12, 2020	SELL	$264.77 - $305.71 $8,472 - $9,782	-32 Reduced 10.6%	270 $77,000
Q2 2020 Aug 13, 2020	SELL	$258.66 - $342.55 $20,692 - $27,404	-80 Reduced 20.94%	302 $81,000
Q1 2020 May 07, 2020	SELL	$268.85 - $341.04 $18,012 - $22,849	-67 Reduced 14.92%	382 $121,000
Q4 2019 Feb 14, 2020	SELL	$220.06 - $304.07 $21,345 - $29,494	-97 Reduced 17.77%	449 $133,000
Q3 2019 Nov 13, 2019	BUY	$217.44 - $243.88 $8,697 - $9,755	40 Added 7.91%	546 $127,000
Q2 2019 Aug 15, 2019	SELL	$219.29 - $241.72 $23,025 - $25,380	-105 Reduced 17.18%	506 $147,000
Q1 2019 Apr 26, 2019	BUY	$216.71 - $338.96 $13,002 - $20,337	60 Added 10.89%	611 $144,000
Q4 2018 Jan 28, 2019	SELL	$278.5 - $352.75 $13,368 - $16,932	-48 Reduced 8.01%	551 $166,000
Q3 2018 Oct 31, 2018	BUY	$293.51 - $383.83 $14,381 - $18,807	49 Added 8.91%	599 $211,000
Q2 2018 Aug 09, 2018	BUY	$257.52 - $306.91 $4,892 - $5,831	19 Added 3.58%	550 $159,000
Q1 2018 May 16, 2018	BUY	$260.13 - $367.91 $73,096 - $103,382	281 Added 112.4%	531 $145,000
Q4 2017 May 18, 2018	BUY	$307.64 - $344.58 $62,450 - $69,949	203 Added 431.91%	250 $178,000
Q4 2017 Mar 07, 2018	BUY	$307.64 - $344.58 $14,459 - $16,195	47	47 $1,000

Others Institutions Holding BIIB

# of Institutions

1,050

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $27.9B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Capital Group, LLC with notifications on news.

Account

Private Capital Group, LLC Biogen Inc. Transaction History